Skip to main content

Table 1 Baseline clinical data from all patients

From: Prediction of invasive candidal infection in critically ill patients with severeacute pancreatitis

 

All patients

Patients without

invasive candidal

infection

Patients with invasive

candidal infection

P value

Number of patients (%)

101

83 (82.2)

18 (17.8)

 

Age, years (median, IQR))

60 (50 to 73)

60 (50-72)

62.5 (44.75 to 76.25)

0.884

Median LOS ICU (days, IQR, range)

8.9 (3.5 to 17.3, 0.1 to 53.1)

7.3 (3.1 to 14.7, 0.1 to 53.2)

16.9 (9.4 to 23.0, 2.2 to 53.1)a

0.004

Male gender (%)

58 (57.4)

48 (57.8)

10 (55.6)

0.999

Median hospital LOS prior to ICU (days, IQR, range)

4 (1 to 12, 0 to 110)

4 (1 to 12, 0 to 110)

4.5 (2 to 13, 0 to 17)

0.125

APACHE II (median, IQR)

16 (12 to 21)

16 (12 to 20.5)

17 (15 to 21.75)

0.445

Mortality, ICU number (%)

18 (17.8)

13 (15.7)

5 (27.8)

0.305

Hospital number (%)

30 (29.7)

20 (24.1)

10 (55.6)a

0.020

Surgery, number (%)

29 (28.7)

22 (26.5)

7 (38.9)

0.389

Severe sepsis, number (%)

37 (36.6)

30 (36.1)

7 (38.9)

0.999

Significant pancreatic necrosis, number (%)

53 (52.5)

40 (48.2)

13 (72.2)

0.063

Pancreatic intervention, number (%)

MIRPN 27 (26.7)

23 (27.7)

4 (22.2)

0.774

 

Open necrosectomy 18 (17.8)

11 (13.3)

7 (38.9)a

0.017

 

Radiologically-guided drain 5 (5)

4 (4.8)

1 (5.6)

0.999

 

Unknown 7 (6.9)

6 (7.2)

1 (5.6)

0.999

 

No intervention 44 (44)

39 (47)

5 (27.8)

0.191

Screened for colonisation with candida, number (%)

95 (94.1)

77 (92.8)

18 (100)

0.588

Total body sites screened

340

269

71

 

Total sites positive for Candida

107

67

40

 

Proportion of sites positive to sites screened

0.31

0.25

0.56

 

Aetiology number (%)

Gallstones 45 (44.6)

38 (45.8)

7 (38.9)

0.794

 

Alcohol 30 (29.7)

25 (30.1)

5 (27.8)

0.999

 

Drugs 1 (1)

0 (0)

1 (5.6)

0.178

 

Other 10 (9.9)

7 (8.4)

3 (16.7)

0.378

 

Idiopathic 3 (3.0)

2 (2.4)

1 (5.6)

0.081

 

Unknown 12 (11.9)

10 (12)

2 (11.1)

0.999

  1. aP <0.05. APACHE II, Acute Physiology and Chronic HealthEvaluation II; LOS ICU, length of stay in the ICU; MIRPN, minimally invasiveretroperitoneal pancreatic necrosectomy.